Experience of using zonisamide in children in routine clinical practice (a multicenter study)

Experience of using zonisamide in children in routine clinical practice (a multicenter study)

Background. The problem of antiepileptic therapy in children remains highly relevant due to the insufficient efficacy of standard drugs, adverse events, and limitations of clinical guidelines.Aim. To assess the efficacy, tolerability, and continuation of zonisamide (Zonegran) therapy in children wit...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. Yu. Bobylova, I. V. Volkov, O. K. Volkova, I. S. Bakhtin, D. I. Gukosyan, O. A. Rakhmanina, M. V. Barkhatov, I. G. Shchukina, Yu. Yu. Kalinina, K. Yu. Mukhin
Format:	Article
Language:	Russian
Published:	ABV-press 2024-07-01
Series:	Русский журнал детской неврологии
Subjects:	zonisamide zonegran epilepsy in children
Online Access:	https://rjdn.abvpress.ru/jour/article/view/472
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

USE OF ZONISAMIDE (ZONEGRAN) IN THE TREATMENT OF EPILEPSY: EMPHASIS ON MONOTHERAPY OF FOCAL SEIZURES (A REVIEW OF FOREIGN LITERATURE)
by: O. A. Pylaeva, et al.
Published: (2015-04-01)

A NEW ANTIEPILEPTIC DRUG — ZONEGRAN (ZONISAMIDE) — IN THE TREATMENT OF EPILEPSY (A REVIEW)
by: O. A. Pylaeva, et al.
Published: (2015-07-01)

Comparative analysis of zonisamide and topiramate use in treatment of pediatric epilepsy in real clinical practice: the results of a retrospective study and related clinical cases
by: O. A. Rakhmanina, et al.
Published: (2020-05-01)

ZONISAMIDE (ZONEGRAN) IN THE TREATMENT OF EPILEPSY IN ADULTS AND CHILDREN (A REVIEW AND CLINICAL CASE)
by: K. Yu. Мukhin, et al.
Published: (2015-04-01)

ZONEGRAN. NEW IN EVIDENTIAL PHARMACOTHERAPY OF EPILEPSY: OPPORTUNITIES AND EXPECTATIONS
by: I. G. Rudakova
Published: (2016-05-01)

Drug-drug interactions in the new antiepileptic drugs: focus to perampanel and zonisamide
by: Y. B. Belousov
Published: (2014-04-01)

Targeting Oxidative Stress and Neuro-Inflammation by Gastrodia elata Improves Disease Outcomes in a Rat Model of Epilepsy
by: Noor-Alhuda Mohammed Alebadi, et al.
Published: (2025-01-01)

Third generation antiepileptic drugs: mechanism of action, pharmacokinetics, interaction and use in childhood
by: Z. G. Tadtaeva, et al.
Published: (2023-07-01)

Dynamics of management of monogenic epilepsies, developmental and epileptic encephalopathies in routine clinical practice
by: О. A. Rakhmanina, et al.
Published: (2025-01-01)

Assessing efficacy and tolerability of lamotrigine (Sazar®) in therapy of female idiopathic generalized epilepsy: a multicenter study
by: M. V. Barkhatov, et al.
Published: (2022-01-01)

Ketogenic Diet: Effects on Growth
by: J Gordon Millichap
Published: (2002-12-01)

Perampanel in the treatment of drug-resistant epilepsy in children
by: M. Yu. Bobylova, et al.
Published: (2018-01-01)

Pharmacological predictors of heart rate and conductivity disorders in juvenile myoclonic epilepsy
by: N. A. Shnayder, et al.
Published: (2021-07-01)

Efficiency of vagus nerve stimulation in epilepsy (literature review and case report)
by: O. A. Pylaeva, et al.
Published: (2019-07-01)

HEMICONVULSION-HEMIPLEGIA-EPILEPSY SYNDROME (HHE SYNDROME) (A LECTURE)
by: K. Yu. Mukhin, et al.
Published: (2015-10-01)

Classification and definition of epilepsy. Position paper by the International League Against Epilepsy on Nosology and Definitions of Epilepsy Syndromes dated 2021
by: K. Yu. Mukhin, et al.
Published: (2022-06-01)

ICTAL EEG IN A PATIENT WITH ROLANDIC EPILEPSY. CASE STUDY
by: I. V. Volkov, et al.
Published: (2016-05-01)

Juvenile Myoclonic Epilepsy. Update
by: I. V. Volkov, et al.
Published: (2020-07-01)

PROSPECTS OF APPLICATION OF NEW ANTIEPILEPTIC DRUGS
by: P. N. Vlasov
Published: (2016-05-01)

The first combined Russian experience of using perampanel in children and adolescents with epilepsy in everyday clinical practice
by: O. A. Rakhmanina, et al.
Published: (2022-09-01)

Efficacy and tolerability of rufinamide in the treatment of epilepsy (experience of the Svt. Luka’s Institute of Child Neurology and Epilepsy)
by: K. Yu. Mukhin, et al.
Published: (2018-11-01)

New possibilities of using perampanel in children. Efficacy and tolerability of perampanel in the treatment of epilepsy (literature review and experience of Svt. Luka’s Association of Medical Institutions)
by: K. Yu. Mukhin, et al.
Published: (2024-11-01)

THE PROBLEMS ASSOCIATED WITH SWITCHING BRAND-NAME ANTIEPILEPTIC DRUGS TO GENERICS: A FOCUS ON TOPAMAX: A REVIEW OF LITERATURE AND A CASE REPORT
by: K. Yu. Mukhin, et al.
Published: (2016-08-01)

MUTATIONS IN THE ARX GENE: CLINICAL, ELECTROENCEPHALOGRAPHIC AND NEUROIMAGING FEATURES IN 3 PATIENTS
by: I. V. Ivanova, et al.
Published: (2017-12-01)

The role of the ketogenic diet in patients with epilepsy. A brief literary review and a clinical example
by: M. Yu. Bobylova, et al.
Published: (2023-06-01)

JUVENILE MYOCLONIC EPILEPSY: FOCUS ON THE USE OF TOPIRAMATE (LITERATURE REVIEW AND OWN DATA)
by: K. Yu. Mukhin, et al.
Published: (2017-08-01)

Efficacy and tolerability of brivaracetam in the treatment of epilepsy: literature review and own experience
by: O. A. Pylaeva, et al.
Published: (2018-11-01)

Mowat-Wilson syndrome: literature review and case series
by: M. Yu. Bobylova, et al.
Published: (2021-11-01)

Treatment priorities for idiopathic generalized epilepsy
by: K. Yu. Mukhin
Published: (2021-07-01)

Genetic epilepsy caused by CDKL5 gene mutations as an example of epileptic encephalopathy and developmental encephalopathy: literature review and own observations
by: K. Yu. Mukhin, et al.
Published: (2021-07-01)

VIDEO-EEG-MONITORING IN DIAGNOSIS OF MYOCLONIC ABSENCES
by: M. B. Mironov, et al.
Published: (2016-06-01)

Pontocerebellar hypoplasia caused by the <i>TSEN54</i> mutation: clinical and electroencephalographic characteristics based on 3 cases
by: M. Yu. Bobylova, et al.
Published: (2024-07-01)

EFFICACY AND TOLERABILITY OF LAMITOR (LAMOTRIGINE) IN THE TREATMENT OF IDIOPATHIC FOCAL AND GENERALIZED EPILEPSY IN MONOTHERAPY AND IN POLYTHERAPY IN CHILDREN AND ADOLESCENTS
by: K. Yu. Mukhin, et al.
Published: (2015-06-01)

Long-term management of patients with epilepsy. Organization of a service in the Tyumen Region
by: E. V. Levitina, et al.
Published: (2016-07-01)

EFFICACY OF VIMPAT (LACOSAMIDE) TN THE TREATMENT OF DRUG-RESISTANT CRYPTOGENIC FOCAL EPILEPSY WITH FOCAL AUTOMOTOR AND SECONDARILY GENERALIZED SEIZURES (A CLINICAL CASE)
by: M. B. Mironov, et al.
Published: (2015-07-01)

Efficacy and tolerability of rufinamide in the treatment of Lennox–Gastaut syndrome (experience of the Svt. Luka’s Association of Medical Institutions)
by: K. Yu. Mukhin, et al.
Published: (2024-01-01)

EPILEPSY IN 11 PATIENTS WITH TYPICAL RETT SYNDROME CAUSED BY MECP2 MUTATION: CLINICAL AND ELECTROENCEPHALOGRAPHIC CHARACTERISTICS, COURSE, THERAPY (RESULTS OF THE AUTHORS’ OBSERVATIONS)
by: M. Yu. Bobylova, et al.
Published: (2016-04-01)

Effectiveness and tolerability of perampanel in сhildren and adolescents (own experience of Svt. Luka’s Institute of Child Neurology and Epilepsy)
by: K. Y. Mukhin, et al.
Published: (2022-01-01)

THE PROBLEM OF AGGRAVATION OF EPILEPTIC SEIZURES DURING THERAPY WITH ANTIEPILEPTIC DRUGS
by: K. Yu. Mukhin, et al.
Published: (2015-04-01)

PHELAN–MCDERMID SYNDROM (del 22q13 AND r(22)): LITERATURE REVIEW AND 2 CASE REPORTS
by: M. Yu. Bobylova, et al.
Published: (2017-02-01)